Cumberland Pharmaceuticals (CPIX) Short-Term Debt issuances (2016 - 2024)
Historic Short-Term Debt issuances for Cumberland Pharmaceuticals (CPIX) over the last 12 years, with Q4 2024 value amounting to $5.5 million.
- Cumberland Pharmaceuticals' Short-Term Debt issuances fell 2857.14% to $5.5 million in Q4 2024 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 8648.28%. This contributed to the annual value of $38.5 million for FY2024, which is 2228.41% up from last year.
- According to the latest figures from Q4 2024, Cumberland Pharmaceuticals' Short-Term Debt issuances is $5.5 million, which was down 2857.14% from $11.0 million recorded in Q3 2024.
- Cumberland Pharmaceuticals' 5-year Short-Term Debt issuances high stood at $20.0 million for Q1 2022, and its period low was $5.5 million during Q4 2024.
- For the 5-year period, Cumberland Pharmaceuticals' Short-Term Debt issuances averaged around $12.0 million, with its median value being $11.0 million (2024).
- In the last 5 years, Cumberland Pharmaceuticals' Short-Term Debt issuances skyrocketed by 8823.53% in 2021 and then plummeted by 6000.0% in 2023.
- Cumberland Pharmaceuticals' Short-Term Debt issuances (Quarter) stood at $15.0 million in 2020, then fell by 6.67% to $14.0 million in 2021, then crashed by 55.71% to $6.2 million in 2022, then increased by 24.19% to $7.7 million in 2023, then dropped by 28.57% to $5.5 million in 2024.
- Its Short-Term Debt issuances was $5.5 million in Q4 2024, compared to $11.0 million in Q3 2024 and $11.0 million in Q2 2024.